Journal of Healthy Ageing and Exercise

Journal of Healthy Ageing and Exercise

The Effect of Eight Weeks of High-Intensity Interval Training and Moderate-Intensity Continuous Training on the Serum FNDC5/Irisin–Cathepsin B/BDNF Muscle-Brain Axis: An Approach for Prescribing and Managing Exercise Programs in Older Adults with Mild Cognitive Impairment

Document Type : Original research

Authors
1 Islamic Azad University, Birjand Branch, South Khorasan, Iran.
2 Islamic Azad University, Birjand Branch
10.22059/jhae.2026.419857.1060
Abstract
Introduction: Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia, with a high prevalence in older adults. The muscle-brain axis, particularly through the FNDC5/irisin and cathepsin B pathways, mediates exercise-induced cognitive effects via BDNF. This study compares the effects of high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) on these pathways in patients with MCI.
Methods: Sixty-nine elderly individuals with MCI (mean age approximately 67 years) were randomly assigned to three groups: control, HIIT, and MICT. The HIIT group performed 4 to 10 one‑minute intervals at 85–90% of HRmax, interspersed with 1–2 minutes of active recovery, while the MICT group performed 25–35 minutes of continuous exercise at 60–70% of HRmax; both programs were conducted for 8 weeks, three sessions per week. Serum levels of FNDC5, irisin, cathepsin B, and BDNF were measured at pre‑test and post‑test using specific ELISA kits. Data analysis was performed using paired t‑test for within‑group changes, mixed‑design repeated‑measures ANOVA with Bonferroni post‑hoc test for between‑group comparisons, and Pearson correlation coefficient to examine relationships among variables, all conducted using SPSS version 27.
Results: Results: Groups were comparable at baseline. Serum levels of BDNF, irisin, cathepsin B, and FNDC5 significantly increased in HIIT and MICT groups (P < 0.001), with no changes in controls. HIIT demonstrated greater increases (75–87%) with large effect sizes. Significant positive correlations were observed among changes in all variables.
Conclusion: Both HIIT and MICT effectively increased serum FNDC5, irisin, cathepsin B, and BDNF in older adults with MCI, with HIIT showing relative superiority. These findings support the muscle-brain axis as a shared biological pathway and suggest both protocols can be considered for cognitive rehabilitation, with HIIT recommended for eligible individuals and MICT as a safer alternative for those with limitations.
Keywords
Subjects

Introduction

Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia, with cognitive decline beyond age/education norms but preserved daily activities. Global prevalence in those ≥50 years is ~15.56%. As an "intervention window" before dementia, non-pharmacological strategies like exercise are critical. The "muscle-brain axis" explains exercise-induced cognitive benefits: muscle contraction releases myokines that cross the blood-brain barrier. The PGC-1α/FNDC5/irisin pathway is key—exercise upregulates FNDC5, cleaved into irisin, which increases hippocampal BDNF and mediates physical activity-hippocampal volume links in older adults. Cathepsin B is another exercise-induced myokine; animal and human studies show it correlates with fitness and memory, acting via BDNF independently of PGC-1α/FNDC5. In older adults, HIIT altered BDNF more than MICT in Alzheimer's, and aerobic exercise changed BDNF and irisin in MCI. No study has compared both pathways (irisin and cathepsin B) simultaneously in HIIT vs. MICT in MCI. Given metabolic differences between HIIT and MICT, differential responses are plausible, which could guide personalized exercise prescription. This study compared 8 weeks of HIIT and MICT on serum FNDC5, irisin, cathepsin B, and BDNF in older adults with MCI.

Methods

This RCT with a three-group parallel and assessor-blind design compared 8 weeks of HIIT and MICT on serum FNDC5, irisin, cathepsin B, and BDNF in older adults with MCI. Two intervention groups and one control group were included. Variables were measured pre- and post-test, with results per CONSORT. Participants were ≥60 years attending a day-care center in Birjand, diagnosed with MCI via clinical exam and cognitive screening. Sample size was calculated using G*Power (effect size: 0.85, α: 0.05, power: 0.80), yielding 18 per group; with 20% attrition, 23 per group enrolled. Random allocation (1:1:1) to HIIT, MICT, or control used random number table, with allocation concealment and blinded outcome assessors. Inclusion: age ≥60; MCI per Petersen; MoCA <26 or <25; independent ADL; no regular exercise for 6 months; medical clearance; informed consent. Exclusion: dementia; unstable CVD; cognition-active medications; chronic inflammation; or <85% attendance. Cognitive status was assessed using validated Persian MoCA/MMSE. Fasting venous blood was collected pre- and post-test, centrifuged, and serum stored at −80°C. FNDC5, irisin, cathepsin B, and BDNF were measured using ELISA kits. Both groups performed 8 weeks of supervised training (3 sessions/week) on treadmill/cycle ergometer with HR monitoring. HIIT included 5–10 min warm-up, 4–10 × 1-min intervals (85–90% HRmax) with active recovery, and cool-down. MICT involved 25–35 min continuous exercise at 60–70% HRmax, with work volume matched to HIIT. RPE was recorded each session. Descriptive data are means ± SD. Normality was tested by Kolmogorov-Smirnov and homogeneity by Levene. Within-group changes used paired t-tests; between-group effects used mixed-design repeated measures ANOVA with Bonferroni post-hoc. Pearson correlation examined relationships. Significance was set at P < 0.05, using SPSS v27.

Results

Baseline characteristics were comparable across HIIT, MICT, and control groups (P > 0.05 for all), confirming homogeneity (Table 3). Mixed-design repeated measures ANOVA revealed significant group × time interactions for all variables (P < 0.001). Serum BDNF, irisin, cathepsin B, and FNDC5 significantly increased from pre- to post-test in both HIIT and MICT groups (P < 0.001), with no changes in controls (P > 0.05). HIIT showed greater increases than MICT for all biomarkers, the largest relative increase was for FNDC5 (87%), followed by cathepsin B (83%), BDNF (80%), and irisin (75%, the smallest of the four in percentage terms).Effect sizes were large for within-group changes (Cohen's d: 1.38–2.82) and between-group effects (partial η²: 0.45–0.52). Pearson correlation analysis revealed significant positive correlations between changes in irisin and BDNF (r = 0.72, P < 0.001), cathepsin B and BDNF (r = 0.68, P < 0.001), and FNDC5 and irisin (r = 0.85, P < 0.001). These findings support the PGC-1α/FNDC5/irisin pathway as a precursor to circulating irisin.

Conclusion

Both HIIT and MICT significantly increased serum FNDC5, irisin, cathepsin B, and BDNF in older adults with MCI versus controls, supporting the muscle-brain axis. HIIT produced greater increases (75–87% higher across the four biomarkers, largest for FNDC5 in percentage terms and largest for irisin in standardized effect size), consistent with Saucedo Marquez et al. and Ceylan et al., who attributed stronger myokine responses to greater metabolic and adrenergic stimulation from interval training. Peng and Wu confirmed FNDC5-derived irisin crosses the blood-brain barrier to enhance hippocampal BDNF, supporting cognition, aligning with our positive FNDC5-irisin correlation. Moon et al. showed running increases cathepsin B, correlating with memory. Gaitán et al. reported increased cathepsin B after 26 weeks of aerobic training in at-risk adults, with only cathepsin B changes, not BDNF or klotho, correlating with cognition. Our positive correlation between cathepsin B-BDNF supports this. The irisin-BDNF correlation confirms Wrann et al. and Pace et al. However, De la Rosa et al. found lower basal BDNF and cathepsin B in long-term exercisers, suggesting responses depend on duration and chronicity. Yu et al. emphasized heterogeneity in cathepsin B evidence. Unlike Enette et al., our HIIT group showed greater BDNF increases, likely due to population differences. Practical implications: both protocols effective, HIIT superior for eligible adults, MICT safer for those with limitations. Safety evidence supports HIIT with proper monitoring. Limitations include small sample and no long-term follow-up. In conclusion, both HIIT and MICT increased myokines and BDNF, with HIIT showing relative superiority, supporting the muscle-brain axis as a shared pathway.

Footnotes

Ethical approval: The present study was conducted following approval from the Research Deputy of Islamic Azad University and the Research Ethics Committee of Islamic Azad University, Birjand Branch, under ethics code IR.IAU.BIRJAND.REC.1405.173.

Funding: The present study received no financial support and had no external funding from any organization or institution.

Authors’ contribution: All authors contributed equally to the study and approved the final manuscript.

Conflict of interest: The authors declare that they have no conflicts of interest.

Acknowledgments: The authors would like to express their sincere gratitude to everyone who supported and assisted us throughout this study.

 

1.    Petersen RC. Mild cognitive impairment. CONTINUUM: lifelong Learning in Neurology. 2016;22(2, Dementia):404-18.
2.    Bai W, Chen P, Cai H, Zhang Q, Su Z, Cheung T, et al. Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies. Age and ageing. 2022;51(8):afac173.
3.    Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The lancet. 2024;404(10452):572-628.
4.    Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463-8.
5.    Han C, Zhou Z, Kong L, Lu J, Li X. Association Between Irisin Level and Cognitive Function: A Systematic Review and Meta‐Analysis. Brain and Behavior. 2025;15(7):e70662.
6.    Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D, et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell metabolism. 2013;18(5):649-59.
7.    Pace T, Levenstein JM, Quigley BL, Houston R, Bouças AP, Andrews SC. The myokine irisin represents an indirect pathway linking exercise to hippocampal subfields relevant to Alzheimer's disease and neurogenesis. Aging Cell. 2026;25(5):e70497.
8.    Moon HY, Becke A, Berron D, Becker B, Sah N, Benoni G, et al. Running-induced systemic cathepsin B secretion is associated with memory function. Cell metabolism. 2016;24(2):332-40.
9.    Enette L, Vogel T, Merle S, Valard-Guiguet A-G, Ozier-Lafontaine N, Neviere R, et al. Effect of 9 weeks continuous vs. interval aerobic training on plasma BDNF levels, aerobic fitness, cognitive capacity and quality of life among seniors with mild to moderate Alzheimer’s disease: a randomized controlled trial. European Review of Aging and Physical Activity. 2020;17(1):2.
10.  Damirchi A, Hosseini F, Babaei P. Mental training enhances cognitive function and BDNF more than either physical or combined training in elderly women with MCI: a small-scale study. American Journal of Alzheimer's Disease & Other Dementias®. 2018;33(1):20-9.
11.  Saucedo Marquez CM, Vanaudenaerde B, Troosters T, Wenderoth N. High-intensity interval training evokes larger serum BDNF levels compared with intense continuous exercise. Journal of applied physiology. 2015;119(12):1363-73.
12.  Yu P, Zhu Z, He J, Gao B, Chen Q, Wu Y, et al. Effects of high-intensity interval training, moderate-intensity continuous training, and guideline-based physical activity on cardiovascular metabolic markers, cognitive and motor function in elderly sedentary patients with type 2 diabetes (HIIT-DM): a protocol for a randomized controlled trial. Frontiers in Aging Neuroscience. 2023;15:1211990.
13.  Petersen RC. Mild cognitive impairment. Continuum. 2007;13(2):15-38.
14.  Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005;53(4):695-9.
15.  Tsai C-L, Chang Y-C, Pan C-Y, Wang T-C, Ukropec J, Ukropcová B. Acute effects of different exercise intensities on executive function and oculomotor performance in middle-aged and older adults: Moderate-intensity continuous exercise vs. high-intensity interval exercise. Frontiers in Aging Neuroscience. 2021;13:743479.
16.  Ceylan Hİ, Öztürk ME, Öztürk D, Silva AF, Albayrak M, Saygın Ö, et al. Acute effect of moderate and high-intensity interval exercises on asprosin and BDNF levels in inactive normal weight and obese individuals. Scientific Reports. 2023;13(1):7040.
17.  Peng J, Wu J. Effects of the FNDC5/Irisin on elderly dementia and cognitive impairment. Frontiers in aging neuroscience. 2022;14:863901.
18.  Yu Q, Zhang Z, Herold F, Ludyga S, Kuang J, Chen Y, et al. Physical activity, cathepsin B, and cognitive health. Trends in Molecular Medicine. 2025;31(7):595-609.
19.  Gaitán JM, Moon HY, Stremlau M, Dubal DB, Cook DB, Okonkwo OC, et al. Effects of aerobic exercise training on systemic biomarkers and cognition in late middle-aged adults at risk for Alzheimer’s disease. Frontiers in Endocrinology. 2021;12:660181.
20.  De la Rosa A, Solana E, Corpas R, Bartrés-Faz D, Pallàs M, Vina J, et al. Long-term exercise training improves memory in middle-aged men and modulates peripheral levels of BDNF and Cathepsin B. Scientific reports. 2019;9(1):3337.
21.  Veronese N, Soysal P, Demurtas J, Solmi M, Bruyère O, Christodoulou N, et al. Physical activity and exercise for the prevention and management of mild cognitive impairment and dementia: a collaborative international guideline. European geriatric medicine. 2023;14(5):925-52.
22.  Rognmo Ø, Moholdt T, Bakken H, Hole T, Mølstad P, Myhr NE, et al. Cardiovascular risk of high-versus moderate-intensity aerobic exercise in coronary heart disease patients. Circulation. 2012;126(12):1436-40.
Volume 2, Issue 2
Summer 2026
Pages 59-75

  • Receive Date 02 July 2026
  • Revise Date 17 August 2026
  • Accept Date 01 September 2026
  • Publish Date 23 August 2026